Alterity Therapeutics (ASX:ATH) - Webinar Presentation

Company Presentations

by Finance News Network

Dr David Stamler, CEO - Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?